Mitsubishi Tanabe Pharma America, Inc.
Registration:
1
of
2
(2018-03-05
to
2020-08-03)
Policies or Program
- Health Canada guidelines and administrative practices with respect to the approval, regulation and life-cycle management of therapeutic products
- Health system policies with respect to pharmaceuticals, including drugs for rare diseases
Policies or Program, Regulation
- Food and Drugs Regulations, specifically with respect to the approval, regulation and life-cycle management of therapeutic products